Study title: A multicenter, randomized, double-blind, placebo-controlled, parallel group study of the safety of zyrtec (cetirizine hydrochloride) syrup in pediatric subjects 6 months to 11 months of age.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Immune System Diseases | |||||
| Brands: | |||||
| MAH holders: | |||||
| Assessment: | |||||
| Active substance: CETIRIZINE | |||||
| ATC code: | |||||
| Document link: A143-1010 - Cetirizine - ARCE02B0405.pdf | |||||
| Document date: 2011-11-28 | |||||
| Study number: ARCE02B0405 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | Y | - | - | |